Related references
Note: Only part of the references are listed.Regulation of splicing enhancer activities by RNA secondary structures
Wei Liu et al.
FEBS LETTERS (2010)
mRNA Secondary Structures Fold Sequentially But Exchange Rapidly In Vivo
Elisabeth M. Mahen et al.
PLOS BIOLOGY (2010)
The cardiac troponin C mutation Leu29Gln found in a patient with hypertrophic cardiomyopathy does not alter contractile parameters in skinned murine myocardium
Axel Neulen et al.
BASIC RESEARCH IN CARDIOLOGY (2009)
Cardiomyopathy Mutations Reveal Variable Region of Myosin Converter as Major Element of Cross-Bridge Compliance
B. Seebohm et al.
BIOPHYSICAL JOURNAL (2009)
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
Francois-Olivier Desmet et al.
NUCLEIC ACIDS RESEARCH (2009)
Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an α- or β-myosin heavy chain backbone
Susan Lowey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Quantification of mutant versus wild-type myosin in human muscle biopsies using nano-LC/ESI-MS
Edgar Becker et al.
ANALYTICAL CHEMISTRY (2007)
Development of a quantitative real-time polymerase chain reaction assay for the detection of the JAK2 V617F mutation
Elizabeth C. Wolstencroft et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes
Natalia N. Singh et al.
NUCLEIC ACIDS RESEARCH (2007)
Prevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy
A Perrot et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Hypertrophic cardiomyopathy-related β-myosin mutations cause highly variable calcium sensitivity with functional imbalances among individual muscle cells
SE Kirschner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Cis-acting regulatory variation in the human genome
T Pastinen et al.
SCIENCE (2004)
Allele-specific gene expression differences in humans
PR Buckland
HUMAN MOLECULAR GENETICS (2004)
Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1
A Zatkova et al.
HUMAN MUTATION (2004)
Hypertrophic cardiomyopathy - Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy
P Richard et al.
CIRCULATION (2003)
Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals
R Jaenisch et al.
NATURE GENETICS (2003)
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy - A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
BJ Maron et al.
EUROPEAN HEART JOURNAL (2003)
Phenotypic diversity in hypertrophic cardiomyopathy
M Arad et al.
HUMAN MOLECULAR GENETICS (2002)
Allelic variation in human gene expression
H Yan et al.
SCIENCE (2002)
Heteroduplexes in mixed-template amplifications: formation, consequence and elimination by 'reconditioning PCR'
JR Thompson et al.
NUCLEIC ACIDS RESEARCH (2002)
Mutation of the myosin converter domain alters cross-bridge elasticity
J Köhler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms
JG Seidman et al.
CELL (2001)
Genomic imprinting: Parental influence on the genome
W Reik et al.
NATURE REVIEWS GENETICS (2001)
Malignant hypertrophic cardiomyopathy caused by the Arg723Gly mutation in β-myosin heavy chain gene
M Enjuto et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Share Paper
